Searching map area
Howard I. Scher
? TBD
researcher
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Works
16
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
scientific article published on 8 May 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer
scientific article published on 9 November 2017
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer
scientific article
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
scientific article
Apalutamide for the treatment of prostate cancer
scientific article published on 01 September 2018
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
scientific article published on 6 March 2014
Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ
scientific article published on December 24, 2014
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
scholarly article by Howard I Scher et al published 1 September 2018 in JAMA Oncology
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone
scientific article published on 17 February 2017
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
scientific article
6 more
Lists
0
Join to rate
Instance of
Human
Occupation
Researcher
Wikidata